cell analysis PerkinElmer Acquiring Nexcelom Bioscience for $260M Nexcelom provides tools for cell counting and analysis, including automated cell counting instruments, image cytometry workstations, and assays. Berkeley Lights to Launch Subscription Option for Smaller Biotech Firms Premium The firm also exercised "buy down" rights to two workflows developed with Ginkgo Bioworks and announced changes to its board of directors. Berkeley Lights Q1 Revenues Grow 35 Percent Berkeley Lights beat the consensus analyst estimate on the top line and matched it on the bottom line as Q1 growth was driven by higher consumables and service revenues. Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy Premium The company believes its combination of deep learning and microfluidic cell sorting could help solve diagnostic challenges and unlock new insights in molecular disease machinery. Berkeley Lights Q4 Revenues Rise 31 Percent The cell analysis firm beat the consensus top line Wall Street estimates for Q4 and full-year 2020, but missed on the bottom line for the year. Feb 25, 2021 10x Genomics Acquires Denmark's Tetramer Shop Jan 20, 2021 Cellink to Distribute Phasefocus High-Content Cell Imaging Platform Jan 5, 2021 LevitasBio Raises $18M in Series B Financing, Forms JV With Thalys Medical in China Jan 5, 2021 Evorion Biotechnologies, Jüke Systemtechnik Partner to Commercialize Cell Analysis System Nov 12, 2020 Berkeley Lights Q3 Revenues Grow 16 Percent Oct 5, 2020 Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells Premium Sep 9, 2020 Adaptive Biotechnologies, Takara Bio T Cell Receptor Sequencing Methods Rank High in Benchmarking Study Premium Aug 25, 2020 Berkeley Lights Q2 Revenues Fall 10 Percent Aug 11, 2020 JP Morgan, Cowen, William Blair Initiate Coverage of Berkeley Lights Jul 17, 2020 Berkeley Lights Prices Upsized $178.2M IPO Jul 14, 2020 Glioblastoma Brain Tumor Treatment Strategies Stem From Pharmacogenomic Analysis Jul 8, 2020 Glioblastoma, Developing Brain Cell Populations Show Similarities in Single-Cell RNA-Seq Study Jun 22, 2020 Stanford Spinout Levitas Bio to Launch Magnetic Levitation Cell Separation Platform Premium May 21, 2020 Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab Premium Apr 29, 2020 Normal Breast Cell Types, States Characterized by Single-Cell Transcriptome Analysis Apr 23, 2020 Harvard Spinout 1CellBio Seeks Ideas for Applications of Targeted Single-Cell Tech Premium Mar 25, 2020 Single-Cell RNA-Seq Study Leads to Cell Type Map of All Major Human Organs Mar 24, 2020 IsoPlexis, Institute for Systems Biology Partner to Identify COVID-19 Immune Mechanisms Dec 19, 2019 RareCyte Raises $22M in Financing Round Dec 9, 2019 PAK4 Inhibition Increases Anti-PD-1 Response in Mouse Models Prompting Phase I Trial Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.